Johns Hopkins Technology Ventures
Overview
Johns Hopkins Technology Ventures (JHTV) is the commercialization and entrepreneurship hub of the university, responsible for fostering a rich innovation ecosystem and bringing Johns Hopkins discoveries to market. JHTV aims to maximize the impact of Johns Hopkins University's research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products and services that benefit society.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kubanda Cryotherapy | Oct 2024 | Seed | Co-investor |
| Adventris Pharmaceuticals | Oct 2023 | Pre Seed | Co-investor |
| AuraSense | Mar 2023 | Accelerator | Co-investor |
| Vita Therapeutics | Jun 2021 | Series A | - |
| Delfi Diagnostics | Jan 2021 | Series A | - |
Key People
Jalil Jalilov
Co-founder Of Azerbaijani Student Association
Michelle Lai
Smart Cookies Nutrition Program Founder
Mindi Levin
Founder And Director, JHU SOURCE
Ona Ambrozaite
Co-Founder Johns Hopkins Science Diplomacy Hub JHU Bloomberg Center Washington, D.C.
Ulviyya Huseynli
Founder And President Of Azerbaijan Student Association
Akshay Mani
Managing Director - Center For Digital Health
Amy Dai
Managing Director, Private Markets
Jennifer Dimitri
Managing Director, Investment Operations
Kimberly Scott
Managing Director
Mark Rooney
Managing Director, Investments
Michelle Kim
Managing Director Of The RNA Innovation Center
Quyet Tran
Managing Director
Christine Ewan
Associate Vice President For Principal Gifts
Giovanna Maria Dora Dore
Associate Professor And EAS Director - Krieger School Of Arts And Sciences TR Track
Lindsay Kubaryk
Director Of Principal Gifts Strategy Fund For Johns Hopkins Medicine
Mary Burke
Director Of Principal Gifts
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
